Literature DB >> 20221785

MAPK/ERK1/2 signaling mediates endothelial-like differentiation of immature DCs in the microenvironment of esophageal squamous cell carcinoma.

Jing Lu1, Jimin Zhao, Kangdong Liu, Jun Zhao, Hongyan Yang, Youtian Huang, Zhenzhu Qin, Ruihua Bai, Pei Li, Junfen Ma, Wenhai Yan, Mingyao Zhao, Ziming Dong.   

Abstract

Endothelial-like differentiation of dendritic cells (DCs) is a new phenomenon, and the mechanism is still elusive. Here, we show that the tumor microenvironment derived from the human esophageal squamous cell carcinoma (ESCC) cell line EC9706 can induce immature DCs (iDCs) differentiate toward endothelial cells, and become endothelial-like cells, but it has no obvious influence on mature DCs. During the course of endothelial-like differentiation of iDCs, a sustained activation of mitogen-activated protein kinase/extracelluar signal-regulated kinase1/2 (MAPK/ERK1/2) and cAMP response element-binding protein (CREB) was detected. Incubation of iDCs with MEK phosphorylation inhibitor PD98059 blocked the MAPK/ERK1/2 and CREB phosphorylation as well as the endothelial-like differentiation of iDCs. Inhibition of vascular endothelial growth factor-A (VEGF-A) in the microenvironment with its antibody blocked the endothelial-like differentiation and the phosphorylation of MAPK/ERK1/2 and CREB. These data suggest that MAPK/ERK1/2 signaling pathway activated by VEGF-A could mediate endothelial-like differentiation of iDCs in the ESCC microenvironment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20221785     DOI: 10.1007/s00018-010-0316-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  53 in total

1.  Evaluation of phagocytic function of macrophages in rats after partial splenectomy.

Authors:  T M Müftüoğlu; N Köksal; D Ozkutlu
Journal:  J Am Coll Surg       Date:  2000-12       Impact factor: 6.113

Review 2.  Growth factor signaling pathways in vascular development.

Authors:  M D Tallquist; P Soriano; R A Klinghoffer
Journal:  Oncogene       Date:  1999-12-20       Impact factor: 9.867

3.  Cutting edge: proangiogenic properties of alternatively activated dendritic cells.

Authors:  Elena Riboldi; Tiziana Musso; Emanuela Moroni; Chiara Urbinati; Sergio Bernasconi; Marco Rusnati; Luciano Adorini; Marco Presta; Silvano Sozzani
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

4.  Identification of a rat bone marrow-derived dendritic cell population which secretes both IL-10 and IL-12: evidence against a reciprocal relationship between IL-10 and IL-12 secretion.

Authors:  Munitta Muthana; Barbara Fairburn; Shabana Mirza; Laura K Slack; Kay Hopkinson; Alan G Pockley
Journal:  Immunobiology       Date:  2006-03-14       Impact factor: 3.144

5.  Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking.

Authors:  G J Randolph; S Beaulieu; S Lebecque; R M Steinman; W A Muller
Journal:  Science       Date:  1998-10-16       Impact factor: 47.728

6.  The MAP kinase pathway controls differentiation from double-negative to double-positive thymocyte.

Authors:  T Crompton; K C Gilmour; M J Owen
Journal:  Cell       Date:  1996-07-26       Impact factor: 41.582

7.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.

Authors:  M Peichev; A J Naiyer; D Pereira; Z Zhu; W J Lane; M Williams; M C Oz; D J Hicklin; L Witte; M A Moore; S Rafii
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

8.  Basic fibroblast growth factor-induced neuronal differentiation of mouse bone marrow stromal cells requires FGFR-1, MAPK/ERK, and transcription factor AP-1.

Authors:  Haijie Yang; Yinyan Xia; Song Qing Lu; Tuck Wah Soong; Zhi Wei Feng
Journal:  J Biol Chem       Date:  2008-01-02       Impact factor: 5.157

9.  Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity.

Authors:  Rakesh Kumar; Victoria B Knick; Sharon K Rudolph; Jennifer H Johnson; Renae M Crosby; Ming-Chih Crouthamel; Teresa M Hopper; Charles G Miller; Laura E Harrington; James A Onori; Robert J Mullin; Tona M Gilmer; Anne T Truesdale; Andrea H Epperly; Amogh Boloor; Jeffrey A Stafford; Deirdre K Luttrell; Mui Cheung
Journal:  Mol Cancer Ther       Date:  2007-07       Impact factor: 6.261

Review 10.  Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications.

Authors:  Ji-Liang Li; Adrian L Harris
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more
  12 in total

1.  VEGFR-1 mediates endothelial differentiation and formation of blood vessels in a murine model of infantile hemangioma.

Authors:  Elisa Boscolo; John B Mulliken; Joyce Bischoff
Journal:  Am J Pathol       Date:  2011-09-21       Impact factor: 4.307

2.  TNFalpha accelerates monocyte to endothelial transdifferentiation in tumors by the induction of integrin alpha5 expression and adhesion to fibronectin.

Authors:  Bin Li; Ambra Pozzi; Pampee P Young
Journal:  Mol Cancer Res       Date:  2011-05-02       Impact factor: 5.852

3.  Dendritic cells loading autologous tumor lysate promote tumor angiogenesis.

Authors:  Yi Yang; Jing Lu; Hangfan Liu; Guoguo Jin; Ruihua Bai; Xiang Li; Dongyu Wang; Jimin Zhao; Youtian Huang; Kangdong Liu; Ying Xing; Ziming Dong
Journal:  Tumour Biol       Date:  2016-10-10

Review 4.  Until Death Do Us Part: Necrosis and Oxidation Promote the Tumor Microenvironment.

Authors:  Ramin Lotfi; Christof Kaltenmeier; Michael T Lotze; Christoph Bergmann
Journal:  Transfus Med Hemother       Date:  2016-03-08       Impact factor: 3.747

5.  Association of MAPK and its regulatory miRNAs (603, 4301, 8485, and 4731) with the malignant transformation of oral lichen planus.

Authors:  Narges Gholizadeh; Amirnader Emami Razavi; Hadiseh Mohammadpour; Fatemeh Tavakol; Nafiseh Sheykhbahaei
Journal:  Mol Biol Rep       Date:  2019-12-11       Impact factor: 2.316

6.  Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition.

Authors:  Dinja Oosterhoff; Sinéad Lougheed; Rieneke van de Ven; Jelle Lindenberg; Hester van Cruijsen; Lotte Hiddingh; Jan Kroon; Alfons J M van den Eertwegh; Basav Hangalapura; Rik J Scheper; Tanja D de Gruijl
Journal:  Oncoimmunology       Date:  2012-08-01       Impact factor: 8.110

Review 7.  Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination.

Authors:  Fabian Benencia; Leslee Sprague; John McGinty; Michelle Pate; Maria Muccioli
Journal:  J Biomed Biotechnol       Date:  2012-03-15

8.  JAK/STAT3 signaling pathway mediates endothelial-like differentiation of immature dendritic cells.

Authors:  Guoguo Jin; Jimin Zhao; Y I Yang; Kangdong Liu; Yanan Jiang; Xiaoyan Zhang; Yanyan Zhang; Youtian Huang; Jing Lu; Ziming Dong
Journal:  Oncol Lett       Date:  2015-09-25       Impact factor: 2.967

9.  ERK signaling is required for VEGF-A/VEGFR2-induced differentiation of porcine adipose-derived mesenchymal stem cells into endothelial cells.

Authors:  Sami G Almalki; Devendra K Agrawal
Journal:  Stem Cell Res Ther       Date:  2017-05-12       Impact factor: 6.832

10.  Combination curcumin and (-)-epigallocatechin-3-gallate inhibits colorectal carcinoma microenvironment-induced angiogenesis by JAK/STAT3/IL-8 pathway.

Authors:  G Jin; Y Yang; K Liu; J Zhao; X Chen; H Liu; R Bai; X Li; Y Jiang; X Zhang; J Lu; Z Dong
Journal:  Oncogenesis       Date:  2017-10-02       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.